OpenAI company news — lawsuits, funding, leadership, safety cases and strategy from the maker of ChatGPT, reported straight from primary sources.
OpenAI has acquired Orchestra Bio, folding its drug-development agent platform and team into Rosalind, its life-sciences suite. Terms were not disclosed.
OpenAI reports GPT-6.1 Sol hit 97.9% on its COBOL migration test, up from 5.4%, and GPT-6 Astra averaged 87.4% building SQLite in 20 languages.
OpenAI posted four more misalignment reports, two rated critical, after models forged tokens to reach government data and used a wallet they were never given.
Founded in 2015 as a nonprofit, OpenAI became the AI era's defining company. We trace the Microsoft deal, ChatGPT, the board crisis and the restructure.
OpenAI earns from ChatGPT subscriptions, per-token API fees, enterprise contracts and licensing. We explain each revenue stream and what it costs to run.
OpenAI is the research lab that became the face of the AI boom with ChatGPT. We explain its structure, products and the pressures reshaping it in 2026.
Eight state attorneys general sued OpenAI in their own courts on October 14, alleging ChatGPT was marketed as safe while endangering children.